Skip to content

Influence of the Immunosystem in Non-celiac Glutensensitivity

Influence of the Immunosystem in Non-celiac Glutensensitivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03268720
Acronym
NCGS
Enrollment
29
Registered
2017-08-31
Start date
2014-04-30
Completion date
2016-12-31
Last updated
2024-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gluten Sensitivity

Keywords

gluten sensitivity, gluten-free diet, FODMAP diet, microbiome

Brief summary

Patients with non-celiac gluten sensitivity (NCGS) complain about gastrointestinal and extraintestinal symptoms while consuming gluten-containing cereals. The symptoms strictly correlate with ingestion of gluten-containing cereals and disappear quickly under elimination diets. Till now, there are no specific markers to diagnose NCGS. This study aims to determine the effect of a low FODMAP diet (fermentable oligo-, di- and monosaccharides and polyols) and a glutenfree diet on the mucosal immunity, clinical symptoms, and psychological well-being. Furthermore, the influence of the diets on the microbiome will be analyzed.

Detailed description

Patients with gluten-sensitivity are rigourously checked for wheat allergy and celiac disease. Genotyping for DQ2/8, serological detection of celiac specific antibodies, and gastroduodenoscopy are performed. Furthermore, a skin prick test and detection of wheat specific IgE are done. After exclusion of celiac disease and wheat allergy patients are considered as patients with NCGS. Patients and healthy controls are asked to consume a low FODMAP diet for two weeks, followed by a 5 day washout and subsequent two week gluten-free diet. At the beginning and the end of each diet the participants fill in questionnaires concerning Nutrition (Freiburger Nutrition protocol), psychological well-being index (PGWB), gastrointestinal symptom Rating score (GSRS), and stool consistency (Bristol stool Chart). Furthermore, stool samples are selected at each time point to determine the microbial pattern. NCGS patients with ongoing complaints will have a second gastroduodenoscopy at the end of the study.

Interventions

OTHERFODMAP low diet

2 week FODMAP low diet

OTHERgluten-free diet

2 week gluten-free diet

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Participants consume a two week lasting low FODMAP diet, followed by 5 days washout, and subsequent two week gluten-free diet.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy controls * patients with glutensensitivity

Exclusion criteria

* patients with glutensensitivity but without celiac disease or wheat allergy

Design outcomes

Primary

MeasureTime frameDescription
Determination of clinical symptomatics2 weeksAnalysis of the improvement of clinical symptoms according to gastrointestinal symptom Rating score
Determination of psychological symptoms2 weeksImprovement of well-being by questionnaire psychological General well-being index

Secondary

MeasureTime frameDescription
Nutrition Analysis for energy intake and nutritional composition by questionnaire Freiburger Nutrition protocol2 weeksDetermination of nutrient intake according to questionnaire Freiburger Nutrition protocol. The questionnaire allows the detailed determination of energy intake, carbohydrates, fatty acids, and Protein.
Intraepithelial lymphocytes4 weeksnumbers of intraepithelial lymphocytes in duodenal mucosa
Goblet cells4 weeksnumbers of Goblet cells in duodenal mucosa
microbiome2 weeksAnalysis of microbiota pattern

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026